A fixed-weight, diversified equity portfolio with a small bond sleeve, rebalanced monthly. It blends tech, healthcare, staples, defense, and financials, with a weekly screen for new ideas.

Plain-language breakdown of the strategy: - What you own: 15 assets (stocks and sector/asset ETFs). Each line shows a ticker (the symbol used to trade the asset) and a name that describes the asset. Some are individual stocks (MSFT, NVDA, MA, etc.), others are ETFs (XLK, ITA, XLP, XLV, TLT). - How much you own: Each asset has a weight, written as a fraction of 100 (e.g., 8/100 means 8%). All weights add up to 100%, so the portfolio is fully invested with no cash by design. - How often it changes: The plan calls for monthly rebalancing to bring holdings back to the target weights after market moves shift them. - Where the exposure sits: The mix is diversified across technology, healthcare, consumer staples, financials, defense, and a bond sleeve (TLT). - What “looks for new stocks weekly” might mean: The description suggests a weekly search for new ideas, but the actual weights shown are fixed. In a real implementation, new ideas could be considered during the weekly scan and only adopted when the monthly rebalance recalibrates the weights. - Why this combination: Heavy tech/AI-related exposure (MSFT, NVDA, AVGO, ORCL) reflects growth potential, while healthcare (LLY, XLV) and staples/defense (XLP, LMT, ITA, WM, COST, MA, CBOE) offer some defensive ballast and diversified exposure. The small bond sleeve (TLT) provides some interest-rate risk ballast rather than pure equity risk. - Key risks: Concentration in tech and a number of sector ETFs means the portfolio can swing a lot with tech cycles. If tech and growth stocks fall, the portfolio could drop despite the defensive pieces. It’s not a described risk-management framework (no stops, risk parity, or volatility targets) beyond fixed weights. - Liquidity and accessibility: All tickers are widely traded, with ETFs generally offering high liquidity and easy diversification for a retail investor. - What you’re not getting: There’s no cash allocation assumption shown; it’s a fully invested model. The plan does not spell out diversification beyond sector exposure or include international assets or small-cap exposure. Overall, this is a structured, high-conviction equity allocation with a modest defensive sleeve and a recurring rebalancing cadence, paired with an ongoing weekly idea-generation process that isn’t fully reflected in the weights.

Out-of-sample strength: 17.3% annualized return, 4.5% max drawdown, Sharpe 1.48, Calmar 3.84, beta 0.74. Superior risk-adjusted growth vs S&P, with tech tilt, bond ballast, and disciplined monthly rebalancing.